ÁªÏµ·½Ê½ ¸üÐÂʱ¼ä£º2022-10-25 16:22:58
- ¹«Ë¾Ãû³Æ£º
- »ùʯҩҵ£¨ËÕÖÝ£©ÓÐÏÞ¹«Ë¾
- ¹«Ë¾µØÖ·£º
- ËÕÖݹ¤ÒµÔ°ÇøÐǺþ½Ö218ºÅÉúÎïÄÉÃ×Ô°A1Â¥±±×ù¶þÂ¥E168µ¥Ôª
- ÁªÏµµç»°£º
- 051****667878;
- ÁªÏµÈË£º
- ÖìÖÒÔ¶
- µç×ÓÓʼþ£º
- zhoul@cstonepharma.com;
¹¤ÉÌÐÅÏ¢ºÍ»ù±¾×ÊÁÏ
- ·¨ÈË´ú±í£º
- ÖìÖÒÔ¶
- ×¢²á×ʱ¾£º
- 1989.7727ÍòÃÀÔª
- ״̬£º
- ÔÚÒµ
- ×¢²áʱ¼ä£º
- 2016-04-21
- ×¢²áµØÖ·£º
- ËÕÖݹ¤ÒµÔ°ÇøÐǺþ½Ö218ºÅÉúÎïÄÉÃ×Ô°A1Â¥±±×ù¶þÂ¥E168µ¥Ôª
- »ÆÒ³·ÖÀࣺ
- Ñо¿ºÍÊÔÑé·¢Õ¹
- ¾Óª·¶Î§£º
- Ñз¢¡¢Éú²ú£ºÒ©Æ·£¬ÏúÊÛ±¾¹«Ë¾×Ô²ú²úÆ·¡££¨ÒÀ·¨Ðë¾Åú×¼µÄÏîÄ¿£¬¾Ïà¹Ø²¿ÃÅÅú×¼ºó·½¿É¿ªÕ¹¾Óª»î¶¯£©
CStonePharmaceuticalsisaninnovative,research-based,biopharmaceuticalcompanycommittedtothedevelopmentofanewgenerationoftherapeuticdrugs.BasedinbothShanghaiandSuzhou,thecompany'sleadershipteamconsistsofseasonedexecutivesfromtoppharmaceuticalMNCs.InJuly2016,CStoneannouncedthecompletionofitsSeriesAfinancing,raisingatotalofUS$150million(about975millionRMB).Threeprestigiousinvestmentcompaniesintheindustry,OrizaSeedVentureCapital(OrizaSeed),BoyuCapital,andWuXiHealthcareVentures(WXHV),jointlyinvestedintheround.WithanoverarchingcommitmenttomeetingthemostpressingneedsofChinesepatients,thecompany'spipelinecoversfivetherapeuticareas,includingoncology,cardiovasculardiseases,rheumatoidarthritis,hematologyandautoimmunediseases.Withimmuno-oncologyasCStone'scoretherapeuticfocus,thecompanystrivestoleadChineseresearchtotheglobalmarketthroughitsworldclassR&Dteam,itsinnovativeportfolio,andanopeninnovationstrategy.
»ùʯҩҵÊÇÒ»¼Ò´´ÐµÄÑз¢Çý¶¯ÐÍÉúÎïÖÆÒ©¹«Ë¾£¬ÖÂÁ¦ÓÚ¿ª·¢ÐÂÒ»´úµÄÖÎÁÆÐÔÒ©Î´´Á¢ÓÚÖйúÉϺ£ºÍËÕÖÝÁ½µØ£¬¹«Ë¾µÄÁìµ¼ÍŶÓÓÉÀ´×Ô¹ú¼Ê¶¥¼âÒ©ÆóµÄ¹ÜÀí²ã³ÉÔ±×é³É¡£2016Äê7ÔÂÐû²¼Íê³ÉAÂÖÈÚ×Ê£¬¹²Ä¼¼¯µ½1.5ÒÚÃÀÔª£¨Ô¼9.75ÒÚÈËÃñ±Ò£©×ʽð£¬ÓÉÈý¼ÒÆľßÉùÍûµÄͶ×ʹ«Ë¾²ÎÓ룬·Ö±ðÊÇÔªºÌԵ㴴ҵͶ×ʹÜÀíÓÐÏÞ¹«Ë¾¡¢²©Ô£×ʱ¾¼°Ø¹³Ð×ʱ¾¡£
Ä¿Ç°£¬»ùʯҩҵӵÓÐÖ×Áö¡¢ÐÄѪ¹Ü¡¢·çʪÐԹؽÚÑס¢ÑªÒº²¡¼°×ÔÉíÃâÒß²¡µÈÎå¸öÖÎÁÆÁìÓòµÄ²úÆ·Ïߣ¬Ö¼ÔÚÂú×ãÖйú²¡»¼ÖØ´óÆÈÇеÄÁÙ´²ÐèÇó¡£ÔÚ¹ãÊÜÖõÄ¿µÄÖ×ÁöÖÎÁÆÁìÓò£¬»ùʯҩҵÒÔÆä³öÉ«µÄÖ×ÁöÃâÒßÒ©ÎïΪºËÐÄ£¬Æ¾½èÆäÊÀ½ç¼¶µÄÑз¢ÍŶӣ¬×îÇ°ÑصÄÒ©ÎïÑз¢ÏîÄ¿£¬ÒÔ¼°¿ª·Åʽ´´ÐµIJßÂÔÓÐÍûÒýÁì¹úÄÚÐÂÒ©Ñз¢ÐÐÒµ×ßÏòÈ«Çò¡£²é¿´¸Ã¹«Ë¾¹¤ÉÌÐÅÏ¢
»ùʯҩҵÊÇÒ»¼Ò´´ÐµÄÑз¢Çý¶¯ÐÍÉúÎïÖÆÒ©¹«Ë¾£¬ÖÂÁ¦ÓÚ¿ª·¢ÐÂÒ»´úµÄÖÎÁÆÐÔÒ©Î´´Á¢ÓÚÖйúÉϺ£ºÍËÕÖÝÁ½µØ£¬¹«Ë¾µÄÁìµ¼ÍŶÓÓÉÀ´×Ô¹ú¼Ê¶¥¼âÒ©ÆóµÄ¹ÜÀí²ã³ÉÔ±×é³É¡£2016Äê7ÔÂÐû²¼Íê³ÉAÂÖÈÚ×Ê£¬¹²Ä¼¼¯µ½1.5ÒÚÃÀÔª£¨Ô¼9.75ÒÚÈËÃñ±Ò£©×ʽð£¬ÓÉÈý¼ÒÆľßÉùÍûµÄͶ×ʹ«Ë¾²ÎÓ룬·Ö±ðÊÇÔªºÌԵ㴴ҵͶ×ʹÜÀíÓÐÏÞ¹«Ë¾¡¢²©Ô£×ʱ¾¼°Ø¹³Ð×ʱ¾¡£
Ä¿Ç°£¬»ùʯҩҵӵÓÐÖ×Áö¡¢ÐÄѪ¹Ü¡¢·çʪÐԹؽÚÑס¢ÑªÒº²¡¼°×ÔÉíÃâÒß²¡µÈÎå¸öÖÎÁÆÁìÓòµÄ²úÆ·Ïߣ¬Ö¼ÔÚÂú×ãÖйú²¡»¼ÖØ´óÆÈÇеÄÁÙ´²ÐèÇó¡£ÔÚ¹ãÊÜÖõÄ¿µÄÖ×ÁöÖÎÁÆÁìÓò£¬»ùʯҩҵÒÔÆä³öÉ«µÄÖ×ÁöÃâÒßÒ©ÎïΪºËÐÄ£¬Æ¾½èÆäÊÀ½ç¼¶µÄÑз¢ÍŶӣ¬×îÇ°ÑصÄÒ©ÎïÑз¢ÏîÄ¿£¬ÒÔ¼°¿ª·Åʽ´´ÐµIJßÂÔÓÐÍûÒýÁì¹úÄÚÐÂÒ©Ñз¢ÐÐÒµ×ßÏòÈ«Çò¡£